Terms of the Award. A. The Company hereby grants to the Participant an aggregate of [ ] FV LTIP Units as of the Effective Date noted above.
Terms of the Award. The terms of the Award are as follows:
Terms of the Award. 3.1 During the continuation of Participant's employment by Federated, the 2019 Award shall vest in Participant in accordance with the schedule of vesting as follows: Date Portion Vested Cumulative Percentage November 18, 2024 100% 100% (restrictions lapse)
Terms of the Award. 3.1 If the Performance Measure Event shall have been attained, then during the continuation of Participant's employment by Federated, the 2018 Award shall vest in Participant in accordance with the schedule of vesting as follows: Date Portion Vested Cumulative Percentage November 17, 2023 100% 100% (restrictions lapse) Notwithstanding the foregoing or any provision of this Agreement to the contrary, if the Board Committee determines, prior to the Disability or death of the Participant, that the Performance Measure Event has not been attained, Participant's rights to the 2018 Award shall be immediately forfeited and Participant shall immediately sell to the Company, and the Company shall purchase from Participant, all Shares at the Purchase Price per Share.
Terms of the Award. The terms of the Award are as follows: Participant: «First_Name» «Middle_Init» «Last_Name» Award Gxxxx Date: _________, 20__ Number of Restricted Shares: _____ Shares of Bxxxx Shoe Company, Inc. Common Stock, subject to certain restrictions Vesting Schedule (Lapse of Restrictions: ____________
Terms of the Award. Certificates for the shares of stock evidencing the Restricted Stock will not be issued but the shares will be registered in your name in book entry form promptly after your acceptance of this Award. You will be entitled to vote and receive any cash dividends (net of required tax withholding) on the Restricted Stock, but you will not be able to obtain a stock certificate or sell, encumber or otherwise transfer the shares except in accordance with the Plan. The number of shares of Restricted Stock you have been awarded is forty five thousand (45,000). Provided since the date of the Award you have been continuously employed or retained as a consultant by the Company or one of its subsidiaries or affiliated companies, the restrictions on 10% of the shares will automatically lapse on July 1, 1997 and on the same date of each year thereafter until all shares are free of restrictions, in each case based on the initial number of shares. In accordance with Section 6(c)(iv) of the Plan, if your employment (or consulting relationship, if applicable) should be terminated by reason of your death or permanent and total disability or if unforfeited shares of Restricted Stock remain unvested and you should die following retirement, the restrictions on all Restricted Stock will lapse and your rights to the shares will become vested on the date of such termination or death. If you are then an employee and your employment should be terminated by reason of retirement on or after your attaining age 65, such restrictions will continue to lapse in the same manner as though your employment had not been terminated. As restrictions lapse, a certificate for the number of shares of Restricted Stock as to which restrictions have lapsed will be forwarded to you or the person or persons entitled to the shares. If your employment or consulting relationship with the Company or one of its subsidiaries or affiliated companies is terminated for any reason while restrictions remain in effect, other than a reason referred to in the second preceding paragraph above, all Restricted Stock for which the restrictions have not lapsed will be automatically forfeited to the Company. Notwithstanding the foregoing, if you at any time engage in an activity following your termination of employment which in the sole judgment of the Committee is detrimental to the interests of the Company, a subsidiary or affiliated company, all Restricted Stock for which restrictions have not lapsed will be forfeited to t...
Terms of the Award. The terms of the Award are as follows: Participant: «First_Name» «Middle_Init» «Last_Name» Award Xxxxx Date: _____, 200_ [**date of board approval] Number of Restricted Shares: ___ Shares of Xxxxx Shoe Company, Inc. Common Stock, subject to certain restrictions Restriction Period: Grant Date through ____ __, 201_as to 100% of the Restricted Shares, subject to earlier vesting as to certain shares as provided herein [** 4th anniversary of the Grant Date] Vesting Schedule (Lapse of Restrictions): ____ __, 201_as to 100% of the Restricted Shares [** 4th anniversary of the Grant Date]
Terms of the Award. 3.1 (a) If the Performance Measure Event shall have been attained, then during the continuation of Participant's employment by Federated, a portion of the 2016 Award shall vest in Participant in accordance with the schedule of vesting as follows: Exhibit 10.83 Date Portion Vested Cumulative Percentage June 15, 2017 5% 5% June 15, 2018 5% 10% June 14, 2019 5% 15% June 15, 2020 5% 20% June 15, 2021 30% 50% (restrictions lapse) June 15, 2022 5% 55% June 15, 2023 5% 60% June 14, 2024 5% 65% June 13, 2025 5% 70% June 15, 2026 30% 100% (restrictions lapse) Exhibit 10.83 Notwithstanding the foregoing or any provision of this Agreement to the contrary, if the Board Committee determines, prior to the Disability or death of the Participant, that the Performance Measure Event has not been attained, Participant's rights to the 2016 Award shall be immediately forfeited and Participant shall immediately sell to the Company, and the Company shall purchase from Participant, all Shares at the Purchase Price per Share.
Terms of the Award. A. Approvals Required Prior to Funding Start Date • Prior to receiving funds, research involving human subjects must have appropriate approvals from the Duke and/or NC State IRB. If the research includes live vertebrate animals, the appropriate IACUC animal research forms must also be approved before the project’s start date. Either an IRB approval letter or an IRB response to a “Determination Whether Research or Similar Activities Require IRB Approval” must be submitted to Duke CTSI prior to funds being released. Human subjects or live vertebrate animal research must be reviewed in accordance with the university’s general assurances and HIPAA. In addition, if the research involves human subjects, all personnel named on the budget page must have certification of training in the protection of human subjects prior to the start of the grant period. • Research involving live vertebrate animals and/or human subjects may also require approval by the National Center for Advancing Translational Sciences (NCATS) prior to receiving funds. The Duke CTSI will request required documents, which includes IRB and/or IACUC approval letters, from the Duke PIs and submit a regulatory package to NCATS for review and approval. NCATS requires up to 30 days for their review. • Failure to submit documents in the requested timeframe may result in cancellation of funding.
Terms of the Award. (a) The Award consists of the aggregate number of FV LTIP Units set forth above (“Award LTIP Units”), which will be subject to forfeiture and vesting as set forth in this Agreement.
